Meeting
2017 Gastrointestinal Cancers Symposium
HSP90 expression and early recurrence in gastroenteropancreatic neuroendocrine tumors: Potential for novel therapeutic targets.
Authors
Cecilia Grace Ethun
Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA
Cecilia Grace Ethun , Lauren McLendon Postlewait , Alexandra Grace Lopez-Aguiar , Kristen Zhelnin , Alyssa Krasinskas , Bassel F. El-Rayes , Maria C. Russell , David A. Kooby , Charles A. Staley III, Kenneth Cardona , Shishir Kumar Maithel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Prevention, Diagnosis, and Screening
Citation
J Clin Oncol 35, 2017 (suppl 4S; abstract 235)
DOI
10.1200/JCO.2017.35.4_suppl.235
Abstract #
235
Poster Bd #
A13
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Gene expression profiling (GEP) to predict the primary site of metastatic neuroendocrine tumors (NETs) presenting with an unknown primary.
First Author: Eugene Woltering
Poster
2021 ASCO Annual Meeting
Assessing safety and activity of cabozantinib combined with lanreotide in gastroenteropancreatic (GEP) and thoracic neuroendocrine tumors (NETs): The phase II LOLA trial.
First Author: Francesca Corti
Poster
2019 Gastrointestinal Cancers Symposium
Resection of primary tumor in liver only metastatic midgut neuroendocrine tumors.
First Author: Nicholas Manguso
Poster
2017 Gastrointestinal Cancers Symposium
Role of surgery for gastric cancer with liver limited multiple metastases.
First Author: Hiromichi Shirasu